2025, StatPearls Publishing Copyright 2025, StatPearls Publishing LLC.: Treasure Island (FL)
A New Chapter in Obesity Management: Oral GLP-1 Therapy Has Arrived The approval of oral semaglutide 25 mg (Wegovy) in the European Union represents more than the introduction of a new formulationit reflects the continued evolution of evidence-based obesity care
These are strictly prescription-based treatments, and you will need to consult a doctor before starting these treatments
A nutritious diet, rich in fruits, vegetables, lean proteins, and whole grains, can complement the effects of semaglutide GLP-1 by supporting overall health and providing essential nutrients
Por otra parte, la compaa Eli Lilly ha desarrollado las pastillas Foundayo, con el ingrediente activo orforglipron